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Letters to the Editor
Relationship Between Coronary
Microcirculatory Function and
Aortic Stiffness in Diabetes
I read with great interest the paper by Cortigiani et al. (1). This
intriguing study confirmed that coronary flow reserve (CFR)
provides independent prognostic information in diabetic and
nondiabetic patients with known or suspected coronary artery
disease (CAD) and negative dipyridamole stress echocardiography.
I feel that a few additional comments are necessary.
It is well known that aortic distensibility and CFR as charac-
teristics of coronary microcirculatory function are reduced in
diabetes mellitus (DM) (2). Moreover, aortic stiffening may lead to
early pulse wave reflection, causing an increase in central systolic
blood pressure (BP), a decrease in diastolic BP, and an increase in
pulse pressure. The elevation in systolic BP increases myocardial
oxygen demand, reduces left ventricular ejection fraction, increases
ventricular overload, and induces left ventricular hypertrophy.
Because myocardial blood supply depends largely on pressure
throughout diastole and the duration of diastole, the contemporary
decrease in diastolic BP can compromise coronary perfusion, resulting
in subendocardial ischemia (3). Reduction in CFR was found in
patients with increased aortic stiffness compared with age-, gender-,
and risk factor-matched controls with normal aortic distensibility (4).
These findings direct our attention to consider aortic stiffness as an
important parameter affecting coronary hemodynamics.
The prognostic role of CFR and DM in patients with known or
suspected CAD has been confirmed, demonstrating that both
variables are independently predictive of cardiovascular survival (5).
In recent studies, it has been demonstrated that CFR and indices
describing aortic distensibility can be measured simultaneously by
echocardiography, helping us better understand their relationship
to each other (4,6). To see whether aortic distensibility could add
predictive value, patients with and without CAD were examined
(7,8). It was found in patients with CAD that aortic distensibility
did not offer any added information in predicting cardiovascular
survival. The potential complementary prognostic value of aortic
distensibility for prediction of cardiovascular mortality over CFR was
found in patients without CAD and abnormal CFR, which should be
the topic of future research (8).
Interestingly, the number of studies evaluating the relationship
between CFR and aortic stiffness in DM is limited (2,9,10).
Alterations were found in CFR and aortic distensibility indices
with correlations in diabetic patients with normal epicardial
coronary arteries (2). In diabetic versus nondiabetic patients with
CAD, aortic distensibility was reduced, but CFR was similar (9).
Moreover, patients with aortic valve stenosis and type 2 DM had
similar CFR and aortic distensibility indices compared with
nondiabetic patients with aortic valve stenosis (10).
It should be considered that theoretically the echocardiographic
evaluation of aortic distensibility simultaneously with CFR mea-
surement is a relatively easy and patient-friendly method. Further
investigations are warranted to examine the direct effect of aortic
stiffness on coronary perfusion, especially in patients with DM.
Furthermore, studies should evaluate the effect of antidiabetic
drugs on coronary perfusion and aortic elasticity as well. Finally,
studies evaluating the prognostic role of a combination of indices
characterizing aortic distensibility and CFR in DM are warranted.
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Reply
We thank Dr. Nemes for the interest in our paper (1). We fully
agree that coronary flow reserve cannot be considered the sole
prognostic parameter in this subset of patients and that other
reliable parameters, along with established and more conventional
ones, should be identified to better characterize these patients. We
do not have data on aortic elasticity because none of our patients
underwent Doppler echocardiography coronary flow reserve during
transesophageal scanning. It is conceivable that this parameter may
add more prognostic information and become clinically useful
when added to coronary flow reserve. However, preliminary data
showed that aortic distensibility did not offer any added value in
predicting cardiovascular survival in patients with coronary artery
disease (2). Moreover, aortic distensibility’s main limitation is the
transesophageal approach, which makes it less appealing for both
patients and physicians. The clinical use of vasodilatory stress
echocardiography stems from a 20-year-old clinical experience. Its
sensitivity and specificity with simple regional wall motion analysis
is high and comparable to other stress imaging modalities, such as
exercise or dobutamine (3). On top of this extensively validated
information on wall motion, coronary flow reserve adds an extra
benefit in diagnostic and prognostic terms without any increase in
imaging time (4). Newer parameters able to identify those at
higher risk of experiencing events, such as diastolic function,
force–frequency relationship as an index of left ventricular con-
tractility (5), are critical and would compose a powerful armamen-
tarium for the cardiologist-echocardiographist, but only after a
careful and through validation. The new parameters will certainly
broaden risk stratification capability of stress echo in the challeng-
ing subset of diabetic patients in the near future. It is, however,
important that the technique, with all its new advances, remains
simple, feasible, and non–time-consuming (6).
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